Please login to the form below

Not currently logged in
Email:
Password:

RNA interference

This page shows the latest RNA interference news and features for those working in and with pharma, biotech and healthcare.

UK’s NICE recommends anti-cholesterol Leqvio for high-risk patients

UK’s NICE recommends anti-cholesterol Leqvio for high-risk patients

The drug is a PCSK9 inhibitor, a novel mechanism of action that uses RNA interference (RNAi) to boost the liver’s ability to remove harmful cholesterol from the blood.

Latest news

More from news
Approximately 1 fully matching, plus 43 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Silence appoints chief medical officer Silence appoints chief medical officer

    These studies involve Silence's investigational portfolio of RNA interference (RNAi) therapeutics, which aim to treat conditions by selectively turning off genes expressed in an individual with a certain disease.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....